About
Company Overview
Kawin Biosciences Singapore Pte. Ltd. is a technology-driven biopharmaceutical company. Adhering to a patient-centric philosophy, Kawin focuses on the discovery, development, and commercialisation of clinically significant innovative drugs and nutritional supplements based on modern bioscience technology platforms. These efforts aim to provide solutions for life-threatening or serious diseases, such as viral infections, liver diseases, and tumours.
Located in Singapore’s Science Park, Kawin has established an innovation research centre that targets new mechanisms and novel targets. Utilising proprietary technologies such as antibody delivery systems and precision protein drug modification for prolonged efficacy, Kawin continually develops its innovative product pipeline through a combination of internal research and strategic partnerships. This approach ensures comprehensive solutions in diagnostics, treatment, and maintenance, ultimately enhancing patient health and quality of life.
Global Presence
Our global presence includes Kawin in Beijing, Kawin Biosciences in Singapore, and Kawin USA in the United States, demonstrating our extensive reach and commitment to serving diverse markets worldwide.
Our Management Team
Dr Wenqi Liu
CEO & Director
– Chairman of Etinpro
(Holding subsidiary of Kawin)
– Rich practical experience in GMP workshop construction, operation and technical team management
Dr Lei Gao
Vice President of R&D
– CEO of Etinpro
– Highly experienced Principal-Scientist of Abbvie with over 10 years of experience in the biopharmaceutical industry
Zixin Liu
Vice President
– Assistant President of Kawin with more than 7 years of experience in operation management and investment management
– IPMP-certified senior project director
